Author

Eloine Garcia

Université Libre de Bruxelles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andrea PavesiiD· 1 shared Benjamin BeckiD· 1 shared Diego Japón-Ruiz· 1 shared Fabiana MoresiiD· 1 shared Katia CoulonvaliD· 1 shared Marta Ávalos-MorenoiD· 1 shared Matteo SerraiD· 1 shared Xavier BisteauiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrea PavesiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CDK4/6 Inhibition Uncovers Subtype-Specific Vulnerabilities and Immune-Related Responses in Esophageal Squamous Cell Carcinoma.

Fabiana Moresi, Diego Japón-Ruiz, Matteo Serra, Marta Ávalos-Moreno, Eloine Garcia, Katia Coulonval, Andrea Pavesi, Benjamin Beck, Xavier Bisteau

This study evaluates palbociclib as a first-line therapy in eSCC, identifying response subtypes and showing immune activation through replication stress and DNA damage.

Cell Death and Disease · May 29, 2026Peer-reviewedCancer Biology